Mark A. Kay

Insider Reports History

Entity
Individual
Location
610 Main Street, 3 Rd Floor, Cambridge, MA
Signature
/s/ Frederic Chereau, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark A. Kay:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LogicBio Therapeutics, Inc. Director Common Stock 0 $2.01 Nov 16, 2022 Direct
LogicBio Therapeutics, Inc. Director Stock Option (right to buy) 0 Nov 16, 2022 Direct

Insider Reports Filed by Mark A. Kay

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LOGC LogicBio Therapeutics, Inc. Nov 16, 2022 4 $0 4 Nov 17, 2022 Director
LOGC LogicBio Therapeutics, Inc. Jun 17, 2022 1 $0 4 Jun 21, 2022 Director
LOGC LogicBio Therapeutics, Inc. Jun 18, 2021 1 $0 4 Jun 21, 2021 Director
LOGC LogicBio Therapeutics, Inc. Jun 11, 2021 1 $0 4 Jun 14, 2021 Director